Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

S&P 500 Healthcare Sector SPDR (XLV)

S&P 500 Healthcare Sector SPDR (XLV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Price/Earnings ttm 16.67
  • Annual Dividend & Yield 2.27 (1.67%)
  • Most Recent Dividend 0.577 on 09/23/24
  • Management Fee 0.10%
  • Sectors:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 15.33% ( -1.26%)
  • Historical Volatility 13.08%
  • IV Percentile 83%
  • IV Rank 59.45%
  • IV High 21.54% on 10/08/24
  • IV Low 6.22% on 02/06/24
  • Put/Call Vol Ratio 1.15
  • Today's Volume 20,101
  • Volume Avg (30-Day) 27,701
  • Put/Call OI Ratio 1.32
  • Today's Open Interest 477,922
  • Open Int (30-Day) 440,154

Price Performance

See More
Period Period Low Period High Performance
1-Month
135.95 +1.51%
on 12/19/24
147.79 -6.62%
on 11/29/24
-4.88 (-3.42%)
since 11/20/24
3-Month
135.95 +1.51%
on 12/19/24
155.21 -11.09%
on 09/23/24
-17.28 (-11.13%)
since 09/20/24
52-Week
133.22 +3.59%
on 12/21/23
159.64 -13.56%
on 09/04/24
+5.27 (+3.97%)
since 12/20/23

Most Recent Stories

More News
Vertex Retail Sentiment Hits Yearly Low On Mixed Neurological Therapy Trial Data, Stock Eyes 7-Month Low

The reduction in pain for suzetrigine was nearly identical to that observed in the placebo arm.

QQQ : 518.66 (+0.87%)
XLV : 138.00 (+1.26%)
VRTX : 397.27 (+0.16%)
SPY : 591.15 (+1.20%)
Pfizer Sparks Analyst Cheer With 2025 Guidance: Retail Maintains Extremely Bullish Stance

Some analysts are optimistic about Pfizer’s potential for growth, especially considering its focus on oncology and recent strategic acquisitions.

XLV : 138.00 (+1.26%)
SCHD : 27.29 (+1.34%)
SPY : 591.15 (+1.20%)
PFE : 26.36 (+2.29%)
Biogen Stock: Is BIIB Underperforming the Healthcare Sector?

Biogen has recently lagged behind the broader healthcare sector, and analysts maintain a cautiously optimistic outlook on the stock's long-term growth potential.

XLV : 138.00 (+1.26%)
GILD : 92.57 (+1.62%)
BIIB : 146.47 (-0.62%)
2025 Market Uncertainty? ETFs to Steady Your Portfolio

Escalating geopolitical tensions and the stalling of the decline in U.S. inflation highlight defensive funds as a smart investment choice. According to Liz Ann Sonders, chief investment strategist at Charles...

XLU : 76.43 (+1.60%)
SPHQ : 67.90 (+0.97%)
XLV : 138.00 (+1.26%)
VHT : 253.89 (+1.23%)
QUAL : 179.43 (+0.97%)
GLDM : 51.98 (+1.05%)
JQUA : 57.99 (+1.10%)
VDC : 213.83 (+0.02%)
FUTY : 48.80 (+1.50%)
VPU : 163.59 (+1.39%)
IYK : 66.03 (+0.44%)
IXJ : 85.87 (+0.25%)
Bristol-Myers Climbs After Jefferies Upgrades Stock On Schizophrenia Drug’s $10B Potential: Retail Is Excited

In September, Bristol-Myers received U.S. approval for Cobenfy, marking the first new class of schizophrenia drug approval in seven decades.

XLV : 138.00 (+1.26%)
SCHD : 27.29 (+1.34%)
SPY : 591.15 (+1.20%)
BMY : 57.33 (+1.83%)
3 Sector ETFs & Stocks to Gain On Upbeat November Jobs Data

The U.S. economy added 227,000 jobs in November 2024, registering a strong recovery from the upwardly revised 36,000 gains in October, which was heavily affected by Boeing strikes and the disruptions caused...

EATZ : 28.43 (+0.50%)
XLV : 138.00 (+1.26%)
XLI : 133.82 (+1.17%)
HCA : 303.62 (+2.05%)
EAT : 134.26 (+2.23%)
CMI : 351.38 (+0.48%)
Zoetis Stock: Is ZTS Underperforming the Healthcare Sector?

Zoetis has recently underperformed the broader healthcare sector, but analysts remain optimistic about its long-term growth prospects.

XLV : 138.00 (+1.26%)
ELAN : 11.63 (-1.61%)
ZTS : 164.84 (+0.81%)
UnitedHealth Stock’s Retail Chatter Spikes As New Details Emerge In Exec’s Shocking Death

Bullet casings found at the scene reportedly had engraved messages, including the words “deny” and “delay.”

XLV : 138.00 (+1.26%)
SPY : 591.15 (+1.20%)
DIA : 428.54 (+1.24%)
UNH : 500.13 (+2.22%)
Gilead Sciences Stock: Is GILD Outperforming the Healthcare Sector?

Gilead Sciences has recently demonstrated strong performance, outperforming the broader healthcare sector, and analysts maintain a cautiously optimistic outlook on its future.

XLV : 138.00 (+1.26%)
GILD : 92.57 (+1.62%)
AMGN : 263.38 (+0.84%)
Pfizer Stock: Is PFE Underperforming the Healthcare Sector?

Despite Pfizer's underperformance relative to the healthcare sector, Wall Street analysts remain moderately optimistic about the stock’s prospects.

XLV : 138.00 (+1.26%)
PFE : 26.36 (+2.29%)
SNY : 47.71 (+0.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Fund Summary

The Health Care Select Sector SPDR Fund seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the Health Care Select Sector Index.

See More

Key Turning Points

3rd Resistance Point 141.42
2nd Resistance Point 140.36
1st Resistance Point 139.18
Last Price 138.00
1st Support Level 136.93
2nd Support Level 135.87
3rd Support Level 134.69

See More

52-Week High 159.64
Fibonacci 61.8% 149.55
Fibonacci 50% 146.43
Fibonacci 38.2% 143.31
Last Price 138.00
52-Week Low 133.22

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar